Celularity Inc (CELU) shareholders
CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.63−0.05 (-7.99%)
Close on Nov 13, 2026Market cap $20.45MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
6.8%
2M of 32M shares
Institutional holders
39
5 new, 4 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Lim Kok Thay Joint filing with Genting Berhad (33.90%), Dragasac Limited (23.80%) and 1 more | 14,138,161 | 41.00% | 13D (active) amendment | Jul 24, 2025 |
| Daniele Barach Joint filing with Philip & Daniele Barach Family Trust (29.00%), Philip A. Barach (29.00%) | 11,940,187 | 29.00% | 13D (active) amendment | Sep 23, 2026 |
| Philip & Daniele Barach Family Trust Joint filing with Philip A. Barach (15.80%), Daniele Barach (15.80%) | 5,514,686 | 15.80% | 13D (active) amendment | Jun 19, 2026 |
| Philp & Daniele Barach Family Trust Joint filing with Philip A. Barach (9.56%), Daniele Barach (9.56%) | 3,012,048 | 9.56% | 13D (active) | Dec 19, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CELU | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| C V Starr & Co Inc | 764,069 | 2.35% | $1.58M | – | 0.84% |
| Vanguard Capital Management LLC | 621,105 | 1.91% | $371.42K | – | 0.00% |
| Geode Capital Management, LLC | 167,150 | 0.52% | $99.96K | −23,926 | 0.00% |
| Citadel Advisors LLC | 99,054 | 0.31% | $59.22K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 79,874 | 0.25% | $47.77K | – | 0.00% |
| BlackRock, Inc. | 76,359 | 0.24% | $45.66K | −51,142 | 0.00% |
| State Street Corp | 57,830 | 0.18% | $34.58K | – | 0.00% |
| Hrt Financial LP | 56,591 | 0.17% | $33.00K | +43,807 | 0.00% |
| Northern Trust Corp | 44,163 | 0.14% | $26.41K | – | 0.00% |
| Biltmore Family Office, LLC | 35,000 | 0.11% | $20.93K | – | 0.00% |
| HB Wealth Management, LLC | 31,915 | 0.10% | $19.08K | −8,500 | 0.00% |
| Keynote Financial Services LLC | 29,920 | 0.09% | $17.89K | +600 | 0.01% |
| Jane Street Group, LLC | 28,713 | 0.09% | $17.17K | New | 0.00% |
| CenterStar Asset Management, LLC | 21,000 | 0.06% | $12.89K | +3,150 | 0.00% |
| Virtu Financial LLC | 18,697 | 0.06% | $11.00K | New | 0.00% |
| Royal Bank of Canada | 18,000 | 0.06% | $11.00K | – | 0.00% |
| IPG Investment Advisors LLC | 17,169 | 0.05% | $10.27K | – | 0.00% |
| IFP Advisors, Inc | 12,000 | 0.04% | $7.18K | +4,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,111 | 0.02% | $3.06K | +1,847 | 0.00% |
| Group One Trading, L.P. | 3,595 | 0.01% | $2.15K | +3,500 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 39 | 2M | 6.8% | 5 / 9 | 4 / 4 | 0M | 0M |
| Q1 2026 | 38 | 2M | 6.7% | 10 / 4 | 5 / 6 | 1M | 0M |
| Q4 2025 | 36 | 2M | 6.8% | 4 / 7 | 7 / 6 | 0M | 0M |
| Q3 2025 | 38 | 2M | 7.1% | 8 / 9 | 8 / 4 | 0M | 0M |
| Q2 2025 | 34 | 2M | 6.8% | 7 / 8 | 8 / 2 | 0M | 0M |
| Q1 2025 | 29 | 2M | 6.1% | 4 / 8 | 3 / 5 | 0M | 0M |
| Q4 2024 | 32 | 2M | 5.7% | 8 / 4 | 7 / 3 | 1M | 0M |
| Q3 2024 | 27 | 1M | 3.0% | 4 / 3 | 6 / 2 | 0M | 0M |
| Q2 2024 | 26 | 1M | 2.9% | 0 / 7 | 8 / 4 | 0M | 0M |
| Q1 2024 | 30 | 1M | 2.6% | 30 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
8 funds held CELU in Q1 2026, 83% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CELU | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 455,049 | 1.40% | $272.07K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 166,056 | 0.51% | $99.28K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 104,816 | 0.32% | $105.86K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 21,176 | 0.07% | $21.39K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 20,677 | 0.06% | $20.88K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 8,438 | 0.03% | $8.52K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Robert J. Hariri | Chief Executive Officer, Director | 2,853,553 | 8.79% | Apr 15, 2026 |
| Stephen Brigido | Pres., Functional Regeneration | 9,742 | 0.03% | Apr 15, 2026 |
| John R. Haines | Senior Exec Vice President | 30,179 | 0.09% | Apr 15, 2026 |
| Joseph DosSantos | Interim CFO | – | – | Jul 16, 2025 |
| David C. Beers | Chief Financial Officer | 18,201 | 0.06% | Apr 15, 2025 |
| Philip Alan Barach | Director, 10% owner | – | – | Sep 25, 2026 |
| Geoffrey M.D. Ling | Director | 256,026 | 0.79% | Jan 15, 2026 |
| Diane L. Parks | Director | 520,021 | 1.60% | Jan 15, 2026 |
| Peter Diamandis | Director | 394,150 | 1.21% | Jan 15, 2026 |
| Vincent LeVien | Director | 153,847 | 0.47% | Jan 15, 2026 |
| Dean C. Kehler | Director | 797,858 | 2.46% | Jan 6, 2025 |
| Richard J. Berman | Director | 67,416 | 0.21% | Jan 6, 2025 |
| Daniele Wolf Barach | 10% owner | – | – | Sep 25, 2026 |
| & Daniele Barach Family Trust Philip | 10% owner | – | – | Sep 25, 2026 |
| Berhad Genting | 10% owner | 6,338,161 | 19.53% | Jul 28, 2025 |
| World Inc Pte. Ltd. Resorts | 10% owner | – | – | Jul 28, 2025 |
| Kok Thay Lim | 10% owner | 30,288,000 | 93.34% | Jul 28, 2025 |
| Ltd Dragasac | 10% owner | 30,062,778 | 92.64% | Jan 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John R. Haines Senior Exec Vice President | Apr 13, 2026 | Tax withholding | −583 | $1.28 | $746 | 30,179 |
| John R. Haines Senior Exec Vice President | Apr 13, 2026 | Option exercise | +1,641 | – | – | 30,762 |
| Stephen Brigido Pres., Functional Regeneration | Apr 13, 2026 | Option exercise | +821 | – | – | 9,742 |
| Stephen Brigido Pres., Functional Regeneration | Apr 13, 2026 | Tax withholding | −268 | $1.28 | $343 | 9,474 |
| Robert J. Hariri Chief Executive Officer, Director | Apr 13, 2026 | Tax withholding | −1,182 | $1.28 | $1.51K | 2,853,553 |
| Robert J. Hariri Chief Executive Officer, Director | Apr 13, 2026 | Option exercise | +3,281 | – | – | 2,854,735 |
| Peter Diamandis Director | Jan 12, 2026 | Award | +20,385 | – | – | 394,150 |
| Diane L. Parks Director | Jan 12, 2026 | Award | +30,000 | – | – | 520,021 |
| Geoffrey M.D. Ling Director | Jan 12, 2026 | Award | +19,231 | – | – | 256,026 |
| Vincent LeVien Director | Jan 12, 2026 | Award | +28,847 | – | – | 153,847 |
| Geoffrey M.D. Ling Director | Jan 12, 2026 | Award | +19,231 | – | – | 256,026 |
| Peter Diamandis Director | Jan 12, 2026 | Award | +20,385 | – | – | 394,150 |
| Vincent LeVien Director | Jan 12, 2026 | Award | +28,847 | – | – | 153,847 |
| Diane L. Parks Director | Jan 12, 2026 | Award | +30,000 | – | – | 520,021 |
| Peter Diamandis Director | Dec 29, 2025 | Award | +125,000 | – | – | 373,765 |
| Diane L. Parks Director | Dec 29, 2025 | Award | +125,000 | – | – | 490,021 |
| Vincent LeVien Director | Dec 29, 2025 | Award | +125,000 | – | – | 125,000 |
| Geoffrey M.D. Ling Director | Dec 29, 2025 | Award | +125,000 | – | – | 236,795 |
| Peter Diamandis Director | Dec 19, 2025 | Award | +67,416 | – | – | 248,765 |
| Diane L. Parks Director | Dec 19, 2025 | Award | +67,416 | – | – | 365,021 |
| Geoffrey M.D. Ling Director | Dec 19, 2025 | Award | +67,416 | – | – | 111,795 |
| Vincent LeVien Director | Nov 19, 2025 | Award | +3,699 | – | – | 3,699 |
| Geoffrey M.D. Ling Director | Nov 19, 2025 | Award | +44,379 | – | – | 111,795 |
| Peter Diamandis Director | Nov 19, 2025 | Award | +47,042 | – | – | 248,765 |
| Diane L. Parks Director | Nov 19, 2025 | Award | +61,539 | – | – | 365,021 |
| Robert J. Hariri Chief Executive Officer, Director | Apr 13, 2025 | Option exercise | +3,281 | – | – | 2,852,608 |
| Robert J. Hariri Chief Executive Officer, Director | Apr 13, 2025 | Tax withholding | −1,154 | $1.64 | $1.89K | 2,851,454 |
| Stephen Brigido Pres., Functional Regeneration | Apr 13, 2025 | Option exercise | +820 | – | – | 9,189 |
| Stephen Brigido Pres., Functional Regeneration | Apr 13, 2025 | Tax withholding | −268 | $1.64 | $440 | 8,921 |
| David C. Beers Chief Financial Officer | Apr 13, 2025 | Tax withholding | −360 | $1.64 | $590 | 18,201 |
| David C. Beers Chief Financial Officer | Apr 13, 2025 | Option exercise | +1,025 | – | – | 18,561 |
| John R. Haines Senior Exec Vice President | Apr 13, 2025 | Option exercise | +1,641 | – | – | 29,698 |
| John R. Haines Senior Exec Vice President | Apr 13, 2025 | Tax withholding | −577 | $1.64 | $946 | 29,121 |
| Robert J. Hariri Chief Executive Officer, Director | Apr 13, 2025 | Option exercise | +3,281 | – | – | 21,482 |
| Robert J. Hariri Chief Executive Officer, Director | Apr 13, 2025 | Tax withholding | −1,154 | $1.64 | $1.89K | 20,328 |
| Stephen Brigido Pres., Functional Regeneration | Feb 17, 2025 | Option exercise | +10,000 | – | – | 11,641 |
| Stephen Brigido Pres., Functional Regeneration | Feb 17, 2025 | Tax withholding | −3,272 | $2.14 | $7.00K | 8,369 |
| John R. Haines Senior Exec Vice President | Feb 17, 2025 | Option exercise | +20,000 | – | – | 35,092 |
| John R. Haines Senior Exec Vice President | Feb 17, 2025 | Tax withholding | −7,035 | $2.14 | $15.05K | 28,057 |
| David C. Beers Chief Financial Officer | Feb 17, 2025 | Option exercise | +12,500 | – | – | 21,932 |
| David C. Beers Chief Financial Officer | Feb 17, 2025 | Tax withholding | −4,396 | $2.14 | $9.41K | 17,536 |
| Berhad Genting 10% owner | Jan 24, 2025 | Option exercise | +652,981 | $2.07 | $1.35M | 6,335,630 |
| Berhad Genting 10% owner | Jan 24, 2025 | Option exercise | +535,274 | $2.07 | $1.11M | 5,682,649 |
| Peter Diamandis Director | Dec 19, 2024 | Award | +67,416 | – | – | 201,723 |
| Diane L. Parks Director | Dec 19, 2024 | Award | +67,416 | – | – | 303,482 |
| Dean C. Kehler Director | Dec 19, 2024 | Award | +67,416 | – | – | 303,482 |
| Richard J. Berman Director | Dec 19, 2024 | Award | +67,416 | – | – | 67,416 |
| Geoffrey M.D. Ling Director | Dec 19, 2024 | Award | +67,416 | – | – | 67,416 |
| Peter Diamandis Director | Dec 19, 2024 | Award | +67,416 | – | – | 1,374,482 |
| Kyle Fletcher See Remarks | Apr 13, 2024 | Tax withholding | −20 | $4.11 | $82 | 21,085 |
| Robert J. Hariri Chief Executive Officer | Apr 13, 2024 | Tax withholding | −1,154 | $4.11 | $4.74K | 2,855,889 |
| David C. Beers Chief Financial Officer | Apr 13, 2024 | Tax withholding | −360 | $4.11 | $1.48K | 23,983 |
| Stephen Brigido Pres, Functional Regeneration | Apr 13, 2024 | Tax withholding | −268 | $4.11 | $1.10K | 19,472 |
| John R. Haines See Remarks | Apr 13, 2024 | Tax withholding | −576 | $4.11 | $2.37K | 38,373 |
| Kyle Fletcher See Remarks | Mar 15, 2024 | Tax withholding | −617 | $5.68 | $3.50K | 21,105 |
| Kyle Fletcher See Remarks | Feb 17, 2024 | Tax withholding | −39,571 | $0.43 | $17.02K | 217,228 |
| David C. Beers Chief Financial Officer | Feb 17, 2024 | Tax withholding | −43,968 | $0.43 | $18.91K | 243,437 |
| John R. Haines See Remarks | Feb 17, 2024 | Tax withholding | −70,350 | $0.43 | $30.25K | 389,497 |
| Adrian Kilcoyne Chief Medical Officer | Feb 17, 2024 | Tax withholding | −52,762 | $0.43 | $22.69K | 1,122,238 |
| Stephen Brigido Pres, Functional Regeneration | Feb 17, 2024 | Tax withholding | −32,720 | $0.43 | $14.07K | 197,406 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
1.65%
1M shares short
Days to cover
2.3
At 0M shares a day
Change since last report
+21.1%
From 0M shares
Short volume, 20 days
56.2%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Celularity's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,289,902 shares on Aug 28, 2026 over the last 90 days.
See a number that looks wrong?